Indirect risks of complementary and alternative medicine: Promises and problems

Wardle, J; Adams, J

Indirect risks of complementary and alternative medicine: Promises and problems

Wardle, J

Adams, J

Permalink

Publisher:: Palgrave Macmillan
Publication Type:: Chapter
Citation:: Traditional, Complementary and Integrative Medicine, 2012, 1, pp. 212 - 219
Issue Date:: 2012-01

Closed Access

	Filename	Description	Size
	2011005957OK.pdf		1.36 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Wardle, J https://orcid.org/0000-0001-8813-3542	en_US
dc.contributor.author	Adams, J https://orcid.org/0000-0002-9901-5717	en_US
dc.contributor.editor	Adams, J https://orcid.org/0000-0002-9901-5717	en_US
dc.contributor.editor	Andrews, G	en_US
dc.contributor.editor	Barnes, J	en_US
dc.contributor.editor	Broom, A	en_US
dc.contributor.editor	Magin, P	en_US
dc.date.issued	2012-01	en_US
dc.identifier.citation	Traditional, Complementary and Integrative Medicine, 2012, 1, pp. 212 - 219	en_US
dc.identifier.isbn	978-0-230-23265-5	en_US
dc.identifier.uri	http://hdl.handle.net/10453/17766
dc.description.abstract	A discussion of issues of safety and risk around complementary and alternative medicine (CAM) has primarily revolved around issues of direct risk, including adverse events (such as the potential hepatotoxicity of CAM products or potential CAM-drug interactions) and the monitoring of these events (pharmacovigilance). Yet the development of a broader public health agenda for CAM (Adams, 2008) provides an opportunity for a new focus on the inherent indirect health risks associated with these medicines - representing a novel, innovative approach to the consideration of risk and safety in CAM.	en_US
dc.publisher	Palgrave Macmillan	en_US
dc.relation.ispartof	Traditional, Complementary and Integrative Medicine	en_US
dc.title	Indirect risks of complementary and alternative medicine: Promises and problems	en_US
dc.type	Chapter
utslib.location	Basingstoke	en_US
utslib.for	1104 Complementary and Alternative Medicine	en_US
utslib.citation.edition	1	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
utslib.copyright.status	closed_access
pubs.consider-herdc	true	en_US
pubs.edition	1	en_US
pubs.place-of-publication	Basingstoke	en_US

Abstract:

A discussion of issues of safety and risk around complementary and alternative medicine (CAM) has primarily revolved around issues of direct risk, including adverse events (such as the potential hepatotoxicity of CAM products or potential CAM-drug interactions) and the monitoring of these events (pharmacovigilance). Yet the development of a broader public health agenda for CAM (Adams, 2008) provides an opportunity for a new focus on the inherent indirect health risks associated with these medicines - representing a novel, innovative approach to the consideration of risk and safety in CAM.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/17766